Fennec Pharmaceuticals annual depreciation and amortization
2011
2012
2013
2023
2024
2025
Fennec Pharmaceuticals Depreciation & Amortization Growth & History (FENC)
Fennec Pharmaceuticals's depreciation and amortization was $103,000 for fiscal 2025.
View full Fennec Pharmaceuticals company overviewFennec Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $103,000 | −$697,000 | −87.13% |
| 2024 | 2024-12-31 | $800,000 | $800,000 | — |
| 2023 | 2023-12-31 | $0 | — | — |
| 2013 | 2013-12-31 | $0 | $0 | — |
| 2012 | 2012-12-31 | $0 | $0 | — |
| 2011 | 2011-12-31 | $0 | — | — |
Fennec Pharmaceuticals quarterly depreciation and amortization
Q1.11
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $25,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $26,000 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $26,000 | — | — |
| Q3 2025 | 2025-09-30 | $26,000 | — | — |
| Q2 2025 | 2025-06-30 | $25,000 | — | — |
| Q1 2025 | 2025-03-31 | $26,000 | — | — |
| Q3 2014 | 2014-09-30 | $0 | $0 | — |
| Q2 2014 | 2014-06-30 | $0 | $0 | — |
| Q1 2014 | 2014-03-31 | $0 | $0 | — |
| Q3 2013 | 2013-09-30 | $0 | $0 | — |
| Q2 2013 | 2013-06-30 | $0 | $0 | — |
| Q1 2013 | 2013-03-31 | $0 | $0 | — |
| Q3 2012 | 2012-09-30 | $0 | $0 | — |
| Q2 2012 | 2012-06-30 | $0 | $0 | — |
| Q1 2012 | 2012-03-31 | $0 | $0 | — |
| Q3 2011 | 2011-09-30 | $0 | — | — |
| Q2 2011 | 2011-06-30 | $0 | — | — |
| Q1 2011 | 2011-03-31 | $0 | — | — |
Fennec Pharmaceuticals depreciation and amortization trends
Between the periods ended 2011-12-31 and 2025-12-31, Fennec Pharmaceuticals's depreciation and amortization increased from $0 to $103,000, a change of $103,000. The latest reported quarter, Q2 2026, shows $25,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Fennec Pharmaceuticals source filings ↗